M2M – The 7th “From Molecule to Man” Track, covering translational developments in Imaging and Therapy will take place during the 33rd Annual Congress of the European Association of Nuclear Medicine in Vienna, Austria, October 17-21 2020.
The 7th M2M Track will take place during the 33rd Annual Congress of the European Association of Nuclear Medicine in Vienna, Austria, October 17-21, 2020.
Since 2014, the M2M sessions have constituted one of the main pillars in the programme of the annual EANM Congress. With the M2M track the EANM aims to actively stimulate multidisciplinary interplay between the various scientific disciplines concerned with molecular/nuclear imaging and therapy. By providing a platform for a wide range of scientific and medical aspects, M2M sessions have succeeded in attracting scientists (e.g. radiochemists, physisists and biologists), industry representatives and clinicians alike. With that, a successful stepping stone for translational science has been established.
The M2M track comprises a series of plenary lectures, CME sessions, symposia and focused scientific sessions, all of which have the aim of connecting fundamental research with unmet medical needs and vice versa.
The EANM Committees for Translational Molecular Imaging and Therapy, Drug Development and Radiopharmacy jointly coordinate the scientific programme of the M2M track, while the EANM Executive Office handles organisational matters.
We look forward to receiving your stimulating scientific abstracts and hope to welcome you at the M2M Track in Vienna in October 2020!
Fijs van Leeuwen, EANM Translational Molecular Imaging and Therapy Committee
Marianne Patt, EANM Radiopharmacy Committee
Johnny Vercouillie, EANM Drug Development Committee
Submitters & Presenters